Genome & Company announces a clinical trial collaboration and supply agreement with Merck KGaA, Darmstadt, Germany and Pfizer

SEOUL, South Korea, Jan. 13, 2020 /PRNewswire/ -- Genome & Company (KONEX: 314130) is pleased to announce that it has entered into a clinical trial collaboration and supply agreement with Merck KGaA, Darmstadt, Germany and Pfizer Inc....
. .
Veröffentlicht von: Finanzen.at - Nachrichten Ticker - 4 days ago

Share |